 鲜花( 85)  鸡蛋( 2)
|
楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval
3 r0 U% {% c) }( F& p: S" j/ ? 3 d1 A* ~" X0 q7 {( f
EDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.! r4 s* X$ R, g5 k5 ^2 Z) l
8 Q! K4 a7 y' J" }
BY THE EDMONTON JOURNAL FEBRUARY 16, 2007: s$ S# a7 |( y j
, F( P }7 U- n+ L$ ~! ~6 U! ?
2 y+ Z, W0 b2 r& X$ Q6 l& P
EDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX." l# f' M/ W7 r6 ^
* ^3 y$ _4 |; G$ R6 ?4 fThe agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM."
0 {0 N; i6 s+ F+ x1 {* U! D
; C9 M* o0 W! cThe APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product.
: y+ ~8 {$ H9 i, b+ O: b. } e- ?/ k
It should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.( g* I" J% {, B; H2 N ^
/ O! n& ?7 L+ N2 P% c4 e
It certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million.
" e; |1 {$ M9 R9 v0 T7 U+ U
* H l0 @9 w1 @3 V( `* D"As a scientist, it's one of the highlights of my CAREER," Shan said.
) d& u9 I1 r( g8 i: F3 X' F7 ?- w5 B% Q5 \$ l2 `; I
"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."+ ]$ b# y# B8 p% Y$ w% R) x
& M9 F1 s c) b+ m( X( w3 b( w3 P
It's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.( a0 F; b& l. e# A4 d
; I3 M& z1 o2 j4 O N) ^, ?9 N0 Y JGinseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.! N* n6 ]: y, h0 r2 Q& F$ ?: c# a
" k- V, i, s/ x, Z `* _The approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman.$ R# Y1 x- ^# n0 v- v1 }
* I$ U Y p. ?0 ?6 {6 I
2 q$ p: K4 ]1 c- a* K8 d% ~http://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|
狗仔卡
发表于 2015-2-28 18:25
5 _1 p- P9 h7 n% H6 n" K O
提升卡
置顶卡
沉默卡
喧嚣卡
变色卡
显身卡
( a0 X1 Q6 F* e; G
发表于 2015-2-28 19:45
